Simple oxygen face masks were patented in the 1950s with relatively little improvement in oxygen delivery; the typical mask delivers ~40-50% oxygen even when run at 15 L of oxygen per minute. Sharp Medical Products, LLC (SMP) has redesigned the face mask from virtually the ground up to create the  O2MAX®.  Several research studies have been performed on O2MAX®. O2MAX® has several critical enhancements that result in increased oxygen delivery of up to 64% more than market leading masks. This game changing technology has been developed in such a way that O2MAX® will not cost more than other masks to manufacture.

Projected commercial release date for O2MAX®  is Summer 2020.